Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.63 USD | +0.08% | +12.26% | -44.32% |
May. 15 | Cabaletta Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 22 | HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.32% | 609M | |
+8.85% | 114B | |
+11.47% | 104B | |
-12.64% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.08% | 17.89B | |
+7.80% | 14.28B | |
+35.67% | 12.55B |
- Stock Market
- Equities
- CABA Stock
- News Cabaletta Bio, Inc.
- HC Wainwright Adjusts Price Target on Cabaletta Bio to $15 From $11, Maintains Buy Rating